National Cancer Institute; Amended Notice of Meeting

---
identifier: "/us/fr/2025-01328"
source: "fr"
legal_status: "authoritative_unofficial"
title: "National Cancer Institute; Amended Notice of Meeting"
title_number: 0
title_name: "Federal Register"
section_number: "2025-01328"
section_name: "National Cancer Institute; Amended Notice of Meeting"
positive_law: false
currency: "2025-01-21"
last_updated: "2025-01-21"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2025-01328"
document_type: "notice"
publication_date: "2025-01-21"
agencies:
  - "Health and Human Services Department"
  - "National Institutes of Health"
fr_citation: "90 FR 7150"
fr_volume: 90
---


#  National Cancer Institute; Amended Notice of Meeting

Notice is hereby given of a change in the meeting of the National Cancer Institute Special Emphasis Panel, TEP-5A: SBIR Review Meeting, March 3, 2025, 11 a.m. to 4 p.m., National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 7W534, Rockville, Maryland, 20850 which was published in the *Federal Register* on December 26, 2024, FR Doc 2024-30711, 89 FR 105062.

This notice is being amended to change the virtual meeting date from March 03, 2025, 11 a.m. to 4 p.m. to March 4, 2025, 11 a.m. to 4 p.m. The meeting times, format, and location will stay the same. The meeting is closed to the public.

Dated: January 14, 2025.

David W. Freeman,

Supervisory Program Analyst, Office of Federal Advisory Committee Policy.